Novel and Cost-Effective Method for Synthesizing Blarcamesine Hydrochloride Using Quality by Design Principles

Blarcamesine hydrochloride is an experimental drug currently in development for treating Alzheimer’s disease and other conditions. The innovator, Anavex Life Sciences Corporation, reported the synthesis of blarcamesine hydrochloride but faced challenges such as low yields and issues with large-scale production, which significantly increased the cost of the drug substance. This report outlines a cost-effective and innovative process for synthesizing blarcamesine hydrochloride amenable to commercial manufacturing. Additionally, we improved the process efficiency by increasing overall throughput.